Drug Profile
Amlodipine/azilsartan - Takeda
Alternative Names: Amlodipine besylate/azilsartan FDC - Takeda; Azilsartan/amlodipine; Azilsartan/amlodipine besylate; TAK-536/amlodipine; TAK-536CCB; ZacrasLatest Information Update: 03 Jul 2019
Price :
$50
*
At a glance
- Originator Takeda
- Class Antihypertensives; Benzimidazoles; Dihydropyridines; Oxadiazoles; Small molecules
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 03 Jul 2019 Chemical structure information added
- 18 Jun 2014 Launched for Hypertension in Japan (PO) - First global launch
- 24 Mar 2014 Registered for Hypertension in Japan (PO) - First global approval